Immortals

2 open roles

Immortals is a longevity medicine company founded by Bryan Johnson and Kate Tolo, built for people who want a data-driven approach to healthspan. It combines prescription treatments such as tirzepatide and metformin, biomarker testing, and personalized protocols delivered through a clinician network and a forthcoming app powered by BryanAI. It sits alongside Blueprint, Johnson's supplement and nutrition line, and sells direct to consumers. For a PM, the interesting part is the mix of regulated telehealth, e-commerce, and AI-driven personalization in one product, with a very public founder shaping the brand.